rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    XAIR
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Beyond Air, Inc. Q2 2027 Earnings Call Summary
      Nov 12Yahoo FinanceXAIR
      Beyond Air Inc (XAIR) (Q2 2027) Earnings Call Highlights: Record Revenue and FDA Review in Focus

      Beyond Air Inc (XAIR) posted record quarterly revenue of $2.3 million and positive gross margin while awaiting FDA approval of its second-generation LungFit PH system.

      Nov 12Yahoo FinanceXAIR
      Beyond Air Q2 2027 Earnings Call Transcript
      Nov 11BenzingaXAIR
      Beyond Air tops revenue estimates with record quarter
      Nov 11Investing.comXAIR
      Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended September 30, 2026
      Oct 29Yahoo FinanceXAIR
      Beyond Air director Lin Yi-Chien buys $5,761 in company stock
      Oct 14Investing.comXAIR
      Beyond Air Reports Record Preliminary Quarterly Revenue Growth

      Tipranks Press Release.

      Oct 9The Globe and MailXAIR
      Beyond Air reports preliminary Q3 revenue of $2.3 million
      Oct 8Investing.comXAIR
      Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026
      Oct 8Yahoo FinanceXAIR
      Air Liquide launches first ever €4 billion buyback under new 2030 strategy
      Oct 5Yahoo FinanceXAIR
      Beyond Air director Lin Yi-Chien buys $56,590 in company stock
      Oct 3Investing.comXAIR
      Beyond Air Formalizes CEO Agreement, Boosts CFO Compensation

      Detailed price information for Beyond Air Inc (XAIR-Q) from The Globe and Mail including charting and trades.

      Sep 25The Globe and MailXAIR
      Beyond Air at cantors conference: generation 2 is the focus
      Sep 10Investing.comXAIR
      Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference

      GARDEN CITY, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that its management team will participate in the 2026 Cantor Global Healthcare Conference, which is being held at the Waldorf Astoria New York, New York on September 9-11, 2026. Fireside Chat Details:Date: Thursday, September 10thTime: 3:55 PM EDT Webc

      Sep 2Yahoo FinanceXAIR
      Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
      Aug 31Yahoo FinanceXAIR
      Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity
      Aug 25Investing.comXAIR
      Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments

      Beyond Air to receive shares representing 19.99% of Univo's issued and outstanding share capital upon closing Beyond Air eligible to receive up to $32.5 million in development and commercial milestone payments GARDEN CITY, N.Y., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) today announced that they have entered into a definitive agreement under which UNIVO Pharmaceutical Industries Ltd (“UNIVO”) Univo Pharmaceutical Industries Ltd. ("UNIVO"), a public company whose shares ar

      Aug 25Yahoo FinanceXAIR

      This is the newest page. Registered accounts read further back.